دورية أكاديمية
أعرض في EDS

Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future.

التفاصيل البيبلوغرافية
العنوان: Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future.
المؤلفون: Ogunleye OO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Lagos 100271, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Lagos 100271, Nigeria., Godman B; Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa., Fadare JO; Department of Pharmacology and Therapeutics, Ekiti State University, Ado Ekiti 362103, Nigeria.; Department of Medicine, Ekiti State University Teaching Hospital, Ado Ekiti 360211, Nigeria., Mudenda S; Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia.; Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka P.O. Box 32379, Zambia., Adeoti AO; Department of Medicine, Ekiti State University Teaching Hospital, Ado Ekiti 360211, Nigeria., Yinka-Ogunleye AF; Nigerian Center for Disease Control, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja 900108, Nigeria., Ogundele SO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Lagos 100271, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Lagos 100271, Nigeria., Oyawole MR; Department of Pharmacy, Lagos State University Teaching Hospital, Lagos 100271, Nigeria., Schönfeldt M; Child, Youth and School Health Directorate, National Department of Health, Pretoria 0083, South Africa., Rashed WM; Children's Cancer Hospital, Egypt-57357 (CCHE-57357), Cairo 11441, Egypt., Galal AM; Biomedical Research Department, Armed Forces College of Medicine, Cairo 11774, Egypt., Masuka N; CIMAS, Cimas House, Borrowdale Office Park, Borrowdale Road, Harare P.O. Box 1243, Zimbabwe., Zaranyika T; Department of Medicine, University of Zimbabwe College of Health Sciences, Harare P.O. Box MP167, Zimbabwe., Kalungia AC; Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia., Malande OO; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa.; Department of Child Health and Paediatrics, Egerton University, Nakuru P.O.Box 536, Kenya.; East Africa Centre for Vaccines and Immunization (ECAVI), Namela House, Naguru, Kampala P.O. Box 3040, Uganda., Kibuule D; Department of Pharmacology & Therapeutics, Busitema University, Mbale P.O. Box 236, Uganda., Massele A; Department of Clinical Pharmacology and Therapeutics, Hurbert Kairuki Memorial University, 70 Chwaku Road Mikocheni, Dar Es Salaam P.O. Box 65300, Tanzania., Chikowe I; Pharmacy Department, Formerly College of Medicine, Kamuzu University of Health Sciences (KUHeS), Blantyre P.O. Box 278, Malawi., Khuluza F; Pharmacy Department, Formerly College of Medicine, Kamuzu University of Health Sciences (KUHeS), Blantyre P.O. Box 278, Malawi., Taruvinga T; Department of Global Health and Development (GHD), London School of Hygiene and Tropical Medicine (LSHTM), London WC1E 7TH, UK., Alfadl A; National Medicines and Poisons Board, Federal Ministry of Health, Khartoum P.O. Box 303, Sudan.; Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia., Malik E; Department of Community Medicine, Faculty of Medicine, University of Khartoum, Khartoum 11111, Sudan., Oluka M; Department of Pharmacology & Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya., Opanga S; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya., Ankrah DNA; Department of Pharmacy, Korle Bu Teaching Hospital, Accra P.O. Box 77, Ghana., Sefah IA; Pharmacy Practice Department, School of Pharmacy, University of Health and Allied Sciences, Hohoe PMB 31, Ghana., Afriyie D; Pharmacy Department, Ghana Police Hospital, Accra P.O. Box CT104, Ghana., Tagoe ET; Department of Management Science, University of Strathclyde, Glasgow G4 0QU, UK., Amu AA; Pharmacy Department, Eswatini Medical Christian University, P.O. Box A624, Swazi Plaza, Mbabane H100, Eswatini., Msibi MP; Faculty of Health Sciences, Department of Medical Laboratory Sciences, Eswatini Medical Christian University, Swazi Plaza P.O. Box A624, Mbabane H100, Eswatini., Etando A; Department of Medical Laboratory Sciences, Faculty of Health Sciences, Eswatini Medical Christian University, Swazi Plaza P.O. Box A624, Mbabane H100, Eswatini., Alabi ME; School of Pharmaceutical Sciences, College of Health Sciences, University of Kwazulu-natal (UKZN), Durban 4001, South Africa., Okwen P; Effective Basic Services (eBASE) Africa, Ndamukong Street, Bamenda 5175, Cameroon.; Faculty of Health and Medical Sciences, Adelaide University, Adelaide 5005, Australia., Niba LL; Effective Basic Services (eBASE) Africa, Ndamukong Street, Bamenda 5175, Cameroon.; Department of Public Health, University of Bamenda, Bambili P.O. Box 39, Cameroon., Mwita JC; Department of Internal Medicine, Faculty of Medicine, University of Botswana, Gaborone P.O. Box 70480, Botswana., Rwegerera GM; Department of Medicine, Sir Ketumile Masire Teaching Hospital, Gaborone P.O. Box 70480, Botswana., Kgatlwane J; Department of Pharmacy, University of Botswana, Gaborone P.O. Box 70480, Botswana., Jairoun AA; Health and Safety Department, Dubai Municipality, Dubai P.O. Box 67, United Arab Emirates.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia., Ejekam C; Department of Community Health, Lagos University Teaching Hospital, Idi-Araba, Lagos PMB 21266, Nigeria., Mavenyengwa RT; Medical Microbiology Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box MP167, Zimbabwe., Murimi-Worstell I; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA., Campbell SM; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa.; Centre for Epidemiology and Public Health, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK., Meyer JC; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa.
المصدر: Vaccines [Vaccines (Basel)] 2022 Sep 17; Vol. 10 (9). Date of Electronic Publication: 2022 Sep 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG
مستخلص: The introduction of effective vaccines in December 2020 marked a significant step forward in the global response to COVID-19. Given concerns with access, acceptability, and hesitancy across Africa, there is a need to describe the current status of vaccine uptake in the continent. An exploratory study was undertaken to investigate these aspects, current challenges, and lessons learnt across Africa to provide future direction. Senior personnel across 14 African countries completed a self-administered questionnaire, with a descriptive analysis of the data. Vaccine roll-out commenced in March 2021 in most countries. COVID-19 vaccination coverage varied from low in Cameroon and Tanzania and up to 39.85% full coverage in Botswana at the end of 2021; that is, all doses advocated by initial protocols versus the total population, with rates increasing to 58.4% in Botswana by the end of June 2022. The greatest increase in people being fully vaccinated was observed in Uganda (20.4% increase), Botswana (18.5% increase), and Zambia (17.9% increase). Most vaccines were obtained through WHO-COVAX agreements. Initially, vaccination was prioritised for healthcare workers (HCWs), the elderly, adults with co-morbidities, and other at-risk groups, with countries now commencing vaccination among children and administering booster doses. Challenges included irregular supply and considerable hesitancy arising from misinformation fuelled by social media activities. Overall, there was fair to reasonable access to vaccination across countries, enhanced by government initiatives. Vaccine hesitancy must be addressed with context-specific interventions, including proactive programmes among HCWs, medical journalists, and the public.
References: Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. (PMID: 25487078)
JAMA. 2020 Apr 28;323(16):1549-1550. (PMID: 32176764)
Am J Health Promot. 2022 Mar;36(3):579-581. (PMID: 35164545)
N Engl J Med. 2021 Feb 25;384(8):693-704. (PMID: 32678530)
Trop Med Health. 2021 May 13;49(1):37. (PMID: 33985592)
J Infect. 2020 Jul;81(1):107-114. (PMID: 32335167)
PLoS One. 2021 Mar 12;16(3):e0245900. (PMID: 33711025)
N Engl J Med. 2021 Feb 11;384(6):497-511. (PMID: 33264556)
Eur J Epidemiol. 2020 Aug;35(8):775-779. (PMID: 32785815)
Life (Basel). 2021 Jun 07;11(6):. (PMID: 34200116)
Basic Clin Pharmacol Toxicol. 2014 Sep;115(3):268-76. (PMID: 24528496)
J Med Internet Res. 2022 Feb 8;24(2):e31726. (PMID: 34783665)
Hum Vaccin Immunother. 2022 Nov 30;18(5):2074716. (PMID: 35714274)
Front Pharmacol. 2014 Jun 17;5:106. (PMID: 24987370)
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311. (PMID: 32191691)
Vaccines (Basel). 2021 Mar 12;9(3):. (PMID: 33809002)
PLoS One. 2022 Apr 21;17(4):e0266724. (PMID: 35446850)
PLoS One. 2022 May 18;17(5):e0268711. (PMID: 35584110)
Trop Med Infect Dis. 2022 Jul 11;7(7):. (PMID: 35878142)
Expert Rev Anti Infect Ther. 2017 Oct;15(10):963-972. (PMID: 28922959)
Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111. (PMID: 35876080)
J Multidiscip Healthc. 2022 Jan 11;15:21-45. (PMID: 35046661)
Expert Rev Vaccines. 2021 Aug;20(8):921-933. (PMID: 34252336)
Emerg Med J. 2020 Sep;37(9):572-575. (PMID: 32651176)
J Environ Manage. 2021 Feb 15;280:111700. (PMID: 33261988)
J R Soc Med. 2021 Jun;114(6):295-298. (PMID: 34077688)
Int J Environ Res Public Health. 2022 May 30;19(11):. (PMID: 35682278)
Lancet. 2022 Mar 5;399(10328):924-944. (PMID: 35202601)
Vaccines (Basel). 2022 Feb 25;10(3):. (PMID: 35334991)
Am J Ther. 2021 Jun 21;28(4):e434-e460. (PMID: 34145166)
BMJ. 2020 Oct 19;371:m4057. (PMID: 33077424)
Future Sci OA. 2021 Jun 10;7(8):FSO736. (PMID: 34290883)
Med (N Y). 2021 May 14;2(5):498-501. (PMID: 33851144)
Oncologist. 2021 Feb;26(2):e342-e344. (PMID: 33210442)
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272. (PMID: 32687792)
PLoS One. 2021 Nov 17;16(11):e0258462. (PMID: 34788308)
Vaccines (Basel). 2021 Nov 19;9(11):. (PMID: 34835290)
Lancet. 2021 Apr 10;397(10282):1348-1349. (PMID: 33773609)
BMC Med Res Methodol. 2013 Sep 18;13:117. (PMID: 24047204)
Antimicrob Resist Infect Control. 2021 Mar 25;10(1):60. (PMID: 33766135)
Front Med (Lausanne). 2022 Jan 27;8:783982. (PMID: 35155467)
JMIR Public Health Surveill. 2021 Nov 17;7(11):e30642. (PMID: 34653016)
Lancet. 2022 Feb 12;399(10325):629-655. (PMID: 35065702)
Pan Afr Med J. 2020 Jul 20;35(Suppl 2):119. (PMID: 33282074)
BMJ Glob Health. 2022 May;7(5):. (PMID: 35618305)
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100899. (PMID: 34746514)
Front Public Health. 2021 Aug 06;9:709127. (PMID: 34422750)
Indian J Pharmacol. 2020 Nov-Dec;52(6):535-550. (PMID: 33666200)
Curr Med Res Opin. 2020 Feb;36(2):301-327. (PMID: 31794332)
Cochrane Database Syst Rev. 2020 Sep 15;9:CD013574. (PMID: 33959956)
PLoS One. 2022 Aug 1;17(8):e0272375. (PMID: 35913964)
Hum Resour Health. 2021 Nov 6;19(1):136. (PMID: 34742301)
Int J Gen Med. 2021 Feb 18;14:515-530. (PMID: 33633461)
PLoS One. 2022 Jan 21;17(1):e0260733. (PMID: 35061702)
BMC Public Health. 2022 Feb 14;22(1):296. (PMID: 35164734)
PLoS One. 2022 Apr 7;17(4):e0266670. (PMID: 35390097)
Hosp Pract (1995). 2020 Mar 14;48(2):51-67. (PMID: 32196395)
BMJ. 2020 May 18;369:m1983. (PMID: 32423901)
J Eval Clin Pract. 2020 Dec;26(6):1592-1598. (PMID: 32970386)
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. (PMID: 32323646)
J Cell Mol Med. 2022 Feb;26(3):636-653. (PMID: 34967105)
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-6. (PMID: 34227914)
Infect Drug Resist. 2020 Dec 29;13:4673-4695. (PMID: 33402839)
Lancet. 2020 Mar 28;395(10229):1015-1018. (PMID: 32197103)
BMC Public Health. 2021 Nov 17;21(1):2113. (PMID: 34789201)
Expert Rev Clin Pharmacol. 2021 Jan;14(1):95-103. (PMID: 33252992)
S Afr J Infect Dis. 2020 Jun 10;35(1):206. (PMID: 34192121)
Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255. (PMID: 31762343)
Vaccine. 2022 Jun 9;40(26):3531-3535. (PMID: 35177301)
PLoS One. 2022 Mar 23;17(3):e0265496. (PMID: 35320309)
Front Med (Lausanne). 2022 May 19;9:820544. (PMID: 35665358)
Int J Environ Res Public Health. 2021 Jan 22;18(3):. (PMID: 33499422)
Lancet Infect Dis. 2022 Sep;22(9):1293-1302. (PMID: 35753318)
Vaccine. 2015 Aug 14;33(34):4161-4. (PMID: 25896383)
Int J Environ Res Public Health. 2022 May 08;19(9):. (PMID: 35565132)
JCO Glob Oncol. 2021 Feb;7:311-323. (PMID: 33617304)
Health Expect. 2022 Feb;25(1):38-47. (PMID: 34748689)
BMJ Glob Health. 2020 Oct;5(10):. (PMID: 33097547)
Front Public Health. 2022 May 09;10:843445. (PMID: 35615034)
Front Pharmacol. 2021 Jan 14;11:588106. (PMID: 33628173)
BMJ. 2021 Aug 26;374:n1931. (PMID: 34446426)
Vaccines (Basel). 2022 Aug 19;10(8):. (PMID: 36016242)
BMJ. 2021 Nov 17;375:e068302. (PMID: 34789505)
Antibiotics (Basel). 2022 Aug 12;11(8):. (PMID: 36009960)
Public Health Pract (Oxf). 2022 Jun;3:100244. (PMID: 35342889)
Vaccines (Basel). 2021 Feb 16;9(2):. (PMID: 33669441)
PLoS One. 2022 Feb 24;17(2):e0264371. (PMID: 35202444)
S Afr Med J. 2021 May 21;111(8):732-740. (PMID: 35227353)
Vaccines (Basel). 2022 Aug 18;10(8):. (PMID: 36016237)
Vaccines (Basel). 2021 Sep 29;9(10):. (PMID: 34696215)
Mayo Clin Proc. 2021 Mar;96(3):699-707. (PMID: 33673921)
Appl Health Econ Health Policy. 2020 Jun;18(3):325-328. (PMID: 32249362)
BMJ Open. 2022 Apr 13;12(4):e059138. (PMID: 35418436)
Vaccines (Basel). 2022 Jul 27;10(8):. (PMID: 35893839)
Lancet HIV. 2020 May;7(5):e308-e309. (PMID: 32272084)
Pan Afr Med J. 2022 Mar 14;41:201. (PMID: 35685114)
N Engl J Med. 2020 Nov 19;383(21):2030-2040. (PMID: 33031652)
Pan Afr Med J. 2022 Feb 09;41:114. (PMID: 35465378)
Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307. (PMID: 35509962)
Hum Vaccin Immunother. 2022 Dec 31;18(1):2027160. (PMID: 35113777)
Nat Hum Behav. 2021 Jul;5(7):947-953. (PMID: 33972767)
J Infect Dev Ctries. 2020 Aug 31;14(8):838-843. (PMID: 32903226)
Ther Adv Infect Dis. 2021 Jun 09;8:20499361211024376. (PMID: 34178323)
Vaccines (Basel). 2021 May 02;9(5):. (PMID: 34063313)
Vaccines (Basel). 2021 Feb 19;9(2):. (PMID: 33669659)
Z Gesundh Wiss. 2022;30(3):583-586. (PMID: 32837842)
PLoS One. 2021 Sep 27;16(9):e0257988. (PMID: 34570798)
Vaccines (Basel). 2021 May 17;9(5):. (PMID: 34067682)
Vaccines (Basel). 2021 Jul 22;9(8):. (PMID: 34451939)
Heliyon. 2022 Sep 13;8(9):e10575. (PMID: 36120496)
Front Public Health. 2020 Dec 14;8:585832. (PMID: 33381485)
J Family Med Prim Care. 2022 Feb;11(2):503-511. (PMID: 35360769)
BMJ. 2021 May 20;373:n1138. (PMID: 34016653)
Pan Afr Med J. 2021 Mar 02;38:230. (PMID: 34046135)
EClinicalMedicine. 2022 Jun 25;50:101499. (PMID: 35770256)
Psychol Med. 2022 Jan;52(2):251-263. (PMID: 32436485)
Int Immunopharmacol. 2022 Aug;109:108906. (PMID: 35671640)
J Med Virol. 2022 Jul;94(7):2969-2976. (PMID: 35246846)
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1273-1280. (PMID: 28776442)
Res Social Adm Pharm. 2021 Jan;17(1):2032-2035. (PMID: 32245691)
Hum Vaccin Immunother. 2021 Nov 2;17(11):4057-4064. (PMID: 34613864)
Front Med (Lausanne). 2022 Feb 02;9:821522. (PMID: 35187005)
QJM. 2021 Dec 20;114(10):721-732. (PMID: 34570241)
BMJ Open. 2021 Dec 15;11(12):e055159. (PMID: 34911723)
Pan Afr Med J. 2021 Jan 05;38:3. (PMID: 33520072)
Vaccines (Basel). 2022 Apr 15;10(4):. (PMID: 35455375)
Front Pharmacol. 2021 May 06;12:584940. (PMID: 34025393)
Immunity. 2021 Jul 13;54(7):1353-1362. (PMID: 34260880)
Curr Opin Immunol. 2020 Aug;65:102-106. (PMID: 33289646)
Pragmat Obs Res. 2020 Oct 29;11:103-109. (PMID: 33154695)
Pan Afr Med J. 2021 Dec 15;40:225. (PMID: 35145587)
Lancet Glob Health. 2022 Feb;10(2):e186-e194. (PMID: 34951973)
Hum Vaccin Immunother. 2022 Dec 31;18(1):1950504. (PMID: 34325612)
Vaccines (Basel). 2022 Jul 29;10(8):. (PMID: 36016102)
Lancet. 2021 Aug 7;398(10299):522-534. (PMID: 34273292)
PLoS Med. 2021 Jul 1;18(7):e1003682. (PMID: 34197449)
Front Public Health. 2020 May 28;8:216. (PMID: 32574299)
Adm Policy Ment Health. 2015 Sep;42(5):533-44. (PMID: 24193818)
Health Policy Technol. 2021 Jun;10(2):100518. (PMID: 34026475)
Soc Sci Med. 2022 Apr;298:114826. (PMID: 35228096)
Lancet. 2020 Oct 24;396(10259):1345-1352. (PMID: 33031764)
Pan Afr Med J. 2022 Feb 08;41:112. (PMID: 35465376)
Front Pharmacol. 2020 Mar 20;11:108. (PMID: 32265688)
Res Social Adm Pharm. 2021 Jan;17(1):1964-1966. (PMID: 32317154)
Vaccines (Basel). 2022 Apr 29;10(5):. (PMID: 35632461)
Int J Health Plann Manage. 2022 May;37(3):1221-1228. (PMID: 35104374)
Glob Health Action. 2022 Dec 31;15(1):2010391. (PMID: 35006037)
Nat Rev Neurol. 2022 Feb;18(2):69-70. (PMID: 34931027)
Front Pharmacol. 2020 Sep 11;11:1205. (PMID: 33071775)
Int J Environ Res Public Health. 2022 Jun 02;19(11):. (PMID: 35682398)
Biomed Pharmacother. 2020 Nov;131:110668. (PMID: 32861965)
Front Pharmacol. 2020 Mar 03;11:144. (PMID: 32194401)
BMC Med. 2022 May 23;20(1):200. (PMID: 35606843)
Sci Rep. 2022 Feb 1;12(1):1709. (PMID: 35105912)
Pan Afr Med J. 2020 Jul 01;35(Suppl 2):97. (PMID: 33623621)
PLoS One. 2021 Dec 1;16(12):e0260575. (PMID: 34851998)
AIDS Res Hum Retroviruses. 2020 Jul;36(7):545-549. (PMID: 32414291)
J Res Pharm Pract. 2021 May 13;10(1):17-22. (PMID: 34295848)
Expert Rev Anti Infect Ther. 2020 Jan;18(1):87-97. (PMID: 31834825)
Public Health. 2021 Aug;197:e18-e19. (PMID: 33714553)
Vaccines (Basel). 2021 Aug 23;9(8):. (PMID: 34452061)
J Med Virol. 2021 Jul;93(7):4280-4291. (PMID: 33644891)
JAMA. 2020 May 26;323(20):2001-2002. (PMID: 32338730)
Int J Environ Res Public Health. 2021 Dec 30;19(1):. (PMID: 35010634)
N Engl J Med. 2021 May 20;384(20):1885-1898. (PMID: 33725432)
Clin Microbiol Infect. 2017 May;23(5):279-280. (PMID: 27851999)
Lancet. 2020 May 30;395(10238):1678-1680. (PMID: 32401713)
Healthcare (Basel). 2021 Dec 13;9(12):. (PMID: 34946448)
Appl Health Econ Health Policy. 2009;7(3):137-47. (PMID: 19799468)
Infect Control Hosp Epidemiol. 2021 Mar;42(3):375-376. (PMID: 32408917)
Ann Med Surg (Lond). 2022 Mar;75:103379. (PMID: 35186288)
Front Pharmacol. 2014 Oct 08;5:219. (PMID: 25339902)
Econ Disaster Clim Chang. 2020;4(3):453-479. (PMID: 32838120)
Antibiotics (Basel). 2022 Mar 25;11(4):. (PMID: 35453198)
Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):527-540. (PMID: 33535841)
PLoS One. 2022 Jun 1;17(6):e0268230. (PMID: 35648745)
معلومات مُعتمدة: MC_PC_16090 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة: Keywords: African countries; COVID-19; availability; challenges; hesitancy; policy implications; social media; vaccination
تواريخ الأحداث: Date Created: 20220923 Latest Revision: 20230322
رمز التحديث: 20230322
مُعرف محوري في PubMed: PMC9504201
DOI: 10.3390/vaccines10091553
PMID: 36146631
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-393X
DOI:10.3390/vaccines10091553